Prostate Cancer Screening Using a Combination of Risk-Prediction, MRI, and Targeted Prostate Biopsies (STHLM3-MRI): a Prospective, Population-Based, Randomised, Open-Label, Non-Inferiority Trial.
Lancet oncology/Lancet Oncology(2021)
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要